花旗

Citigroup in defensive mode with poison pill

Citigroup yesterday introduced a “poison pill” that discourages investors from buying more than 5 per cent of its shares and deters large shareholders from raising their stakes in an effort to protect a $43bn tax benefit.

Citi's surprise move came as the company launched its long-awaited $58bn conversion of preferred shares into common stock, which will leave the US government with a 34 per cent stake and help the bank bolster its battered balance sheet.

Citi's executives argued that the rare provision was not a classic “poison pill” designed to thwart takeover attempts because it would not be triggered if the bank received a bid.

您已阅读30%(636字),剩余70%(1501字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归manbetx20客户端下载 所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×